Age at onset and regional cerebral glucose metabolism in Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 9, Issue 2, 1998, Pages 63-67

  Yasuno, Fumihiko ^a   Imamura, Toru ^a   Hirono, Nobutsugu ^a   Ishii, Kazunari ^a   Sasaki, Masahiro ^a   Ikejiri, Yoshitaka ^a   Hashimoto, Mamoru ^a   Shimomura, Tatsuo ^a   Yamashita, Hikari ^a   Mori, Etsuro ^a  

^a Hyogo Inst Aging Brain Cogn D   (Japan)

Author keywords

Age at onset; Alzheimer's disease; Association cortex; Cerebral glucose metabolism; Paralimbic area; Positron emission tomography

Indexed keywords

GLUCOSE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; GLUCOSE METABOLISM; HUMAN; LIMBIC CORTEX; MALE; METABOLIC RATE; ONSET AGE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL CORTEX;

EID: 6844265569     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017024     Document Type: Article

References (36)

1. Raskind AM, Carta A, Bravi D: Is early-onset Alzheimer disease a distinct subgroup within Alzheimer disease population? Alzheimer Dis Assoc Disord 1995;9:2-6.
2. Harvey RJ, Rossor MN: Does early-onset Alzheimer disease constitute a distinct subtype? The contribution of molecular genetics. Alzheimer Dis Assoc Disord 1995;9(suppl 1):S7-S13.
3. Selzer B, Sherwin I: A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two? Arch Neurol 1983;40:143-146.
4. Chui HC, Teng EL, Henderson VW, Moy AC: Clinical subtypes of dementia of the Alzheimer type. Neurology 1985;35:1544-1550.
5. Filley CM, Kelly J, Heaton RK: Neurolopsychologic features of early- and late onset Alzheimer's disease. Arch Neurol 1986;43:574-576.
6. Blennow K, Wallin A: Clinical heterogeneity of probable Alzheimer's disease. J Geriatr Psychiatry Neurol 1988;5:106-113.
7. Becker JT, Huff FJ, Nebes RD, Holland A, Boller F: Neuropsychological function in Alzheimer's disease. Pattern of impairment and rates of progression. Arch Neurol 1988;45: 263-268.
8. Jacobs D, Sano M, Marder K, Bell K, Bylsma F, Lafleche G, Albert M, Brandt J, Stern Y: Age at onset of Alzheimer's disease. Relation to pattern of cognitive dysfunction and rate of decline. Neurology 1994;44:1215-1220.
9. Sevush S, Leve N, Brickman A: Age at disease onset and pattern of cognitive impairment in probable Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1993;5:66-72.
10. Koss E, Edland S, Fillenbaum G, Mohs R, Clark C, Galasko D, Morris JC: Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease. A CERAD analysis. XII. Neurology 1996;46:136-141.
11. Mortimer JA, Ebbitt B, Jun SP, Finch MD: Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology 1992;42:1689-1696.
12. Lucca U, Comelli M, Tettamanti M, Tiraboschi P, Spagnoli A: Rate of progression and prognostic factors in Alzheimer's disease: A prospective study. J Am Geriatr Soc 1993;41: 45-49.
13. Binetti G, Magni E, Padovani A, Cappa SF, Bianchetti A, Trabucchi M: Neuropsychological heterogeneity in mild Alzheimer's disease. Dementia 1993;4:321-326.
14. Mann DMA, Yates PO, Marcyniuk B: Monoaminergic neurotransmitter systems in presenile Alzheimer's disease and in senile dementia of Alzheimer type. Clin Neuropathol 1984;10: 185-207.
15. Bondareff W, Mountjoy CQ, Roth M, Rossor MN, Iversen LL, Reynolds GP: Age and histopathologic heterogeneity in Alzheimer's disease. Evidence of subtypes. Arch Gen Psychiatry 1987;44:412-417.
16. Nochlin D, van Belle G, Bird TD, Sumi SM: Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease. Alzheimer Dis Assoc Disord 1993;7: 212-222.
17. Bird TD, Stranahan S, Sumi SM, Raskind M: Alzheimer's disease: Choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Ann Neurol 1983;14:284-293.
18. Rossor MN, Iversen LL, Reynolds GP, Rossor MN, Iversen LL, Reynolds GP: Neurochemical characteristics of early and late onset types of Alzheimer's disease. BMJ 1984;288:961-964.
19. Bondareff W, Mountjoy CQ, Roth M: Loss of neurons of origine of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 1982;32:164-168.
20. Koss E, Friedland RP, Ober BA, Jagust WJ: Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer type dementia. Am J Psychiatry 1985;142:638-640.
21. Grady CL, Haxby JV, Horwitz B, Berg G, Rapoport SI: Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type. Neuropsychologia 1987;25:807-816.
22. Small GW, Kuhl DE, Riege WH, Fujikawa DG, Ashford JW, Metter EJ, Mazziotta JC: Cerebral glucose metabolic patterns in Alzheimer's disease. Arch Gen Psychiatry 1989; 46:527-532.
23. Mielke R, Herholz K, Grond M, Kessler J, D-Heiss W: Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type. Neurobiol Aging 1991;13:93-98.
24. Mckhann G, Drachman D, Folstein M, Katzman R, Price D, Standlan EM: Clinical diaposis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
25. Folstein MF, Folstein SE, McHugh PR: 'Mini-Mental State': A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
26. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
27. Morris JC: The clinical dementia rating (CDR): Current version and scoring rules. Neurology 1993;43:2412-2414.
28. Iida H, Miura S, Kanno I, Murakami M, Takahashi K, Uemura K, Hirose K, Amano M, Yamamoto S, Tanaka K: Design of evaluation of Headtome IV: A whole body positron emission tomograph. IEEE Trans Nucl Sci 1989;37: 1006-1010.
29. Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, Matuda K, Mori E: Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J Nucl Med 1997;38:925-928.
30. 14C]deoxy glucose method for the measurement of local cerebral glucose utilization, theory, procedure, and normal values in the conscious and anaesthetized albino rat. J Neurochem 1977;28:897-916.
31. 11C] deoxyglucose. J Cereb Blood Flow Metab 1985;5:179-192.
32. Ishii K, Kitagaki H, Kono M, Mori E: Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by positron emission tomography. J Nucl Med 1996;37:1159-1165.
33. Brun A, Gustafson L: Distribution of cerebral degeneration in Alzheimer's disease: A clinico-pathological study. Arch Psychiatry Nervenkr 1976;223:15-33.
34. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS: Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc Natl Acad Sci USA 1985;82:4531-4534.
35. SAS Institute: SAS/STAT Users Guide, Release 6.03 Edition. Cary, SAS Institute, 1988.
36. Hyman BT: Alzheimer's disease or Alzheimer's diseases? Clues from molecular epidemiology. Ann Neurol 1996;40:135-136.